Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sameh Saber

Showing results (11-20 of 141) with videos related to

Pageof 15
Sort By:
Diagnostics (Basel, Switzerland)|March 29, 2023
Evaluation of the Corneal Endothelium Following Cataract Surgery in Diabetic and Non-Diabetic PatientsAdela-Laura Ciorba, George Roiu, Amir Mohamed Abdelhamid, et al.
Inflammopharmacology|May 18, 2021
Dapagliflozin, an SGLT2 inhibitor, ameliorates acetic acid-induced colitis in rats by targeting NFκB/AMPK/NLRP3 axisMagdy Abou El-Rous, Sameh Saber, Eman M Raafat, et al.
Pharmaceuticals (Basel, Switzerland)|March 6, 2021
Novel Potent and Selective DPP-4 Inhibitors: Design, Synthesis and Molecular Docking Study of Dihydropyrimidine Phthalimide HybridsAhmed A E Mourad, Ahmed E Khodir, Sameh Saber, et al.
Toxicology and Applied Pharmacology|December 31, 2018
Olmesartan ameliorates chemically-induced ulcerative colitis in rats via modulating NFκB and Nrf-2/HO-1 signaling crosstalkSameh Saber, Rania M Khalil, Walied S Abdo, et al.
International Immunopharmacology|May 13, 2025
Verapamil inhibits TXNIP-dependent NLRP3 Inflammasome activation in an ulcerative colitis rat model: A new evolving role of the calcium channel blockerAhmed Shawky, Sameh Saber, Eman M Abd El-Kader, et al.
AMB Express|March 5, 2025
The coadministration of Lactobacillus probiotic augments the antitumor effect of telmisartan in ratsAhmed M El-Baz, Amany A El-Mahmoudy, Sameh Saber, et al.
International Immunopharmacology|November 8, 2024
Diltiazem mitigates acute liver injury by targeting NFκB-TXNIP/NLRP3 axis in Rats: New insights beyond calcium channel blockadeFatma Elnaghy, George S G Shehatou, Eman M Abd El-Kader, et al.
Molecular Pharmaceutics|August 16, 2023
Lactosylated Chitosan Nanoparticles Potentiate the Anticancer Effects of Telmisartan In Vitro and in a <i>N</i>-Nitrosodiethylamine-Induced Mice Model of Hepatocellular CarcinomaMohamed Nasr, Ahmed Y Kira, Sameh Saber, et al.
AAPS Pharmscitech|June 23, 2023
Telmisartan-Loaded Lactosylated Chitosan Nanoparticles as a Liver Specific Delivery System: Synthesis, Optimization and Targeting EfficiencyMohamed Nasr, Ahmed Y Kira, Sameh Saber, et al.
Cancer Chemotherapy and Pharmacology|January 29, 2020
Novel complementary antitumour effects of celastrol and metformin by targeting IκBκB, apoptosis and NLRP3 inflammasome activation in diethylnitrosamine-induced murine hepatocarcinogenesisSameh Saber, Amal M H Ghanim, Eman El-Ahwany, et al.
Pageof 15

Showing results (11-20 of 141) with videos related to

Sort By:
Pageof 15
Diagnostics (Basel, Switzerland)|March 29, 2023
Evaluation of the Corneal Endothelium Following Cataract Surgery in Diabetic and Non-Diabetic PatientsAdela-Laura Ciorba, George Roiu, Amir Mohamed Abdelhamid, et al.
Inflammopharmacology|May 18, 2021
Dapagliflozin, an SGLT2 inhibitor, ameliorates acetic acid-induced colitis in rats by targeting NFκB/AMPK/NLRP3 axisMagdy Abou El-Rous, Sameh Saber, Eman M Raafat, et al.
Pharmaceuticals (Basel, Switzerland)|March 6, 2021
Novel Potent and Selective DPP-4 Inhibitors: Design, Synthesis and Molecular Docking Study of Dihydropyrimidine Phthalimide HybridsAhmed A E Mourad, Ahmed E Khodir, Sameh Saber, et al.
Toxicology and Applied Pharmacology|December 31, 2018
Olmesartan ameliorates chemically-induced ulcerative colitis in rats via modulating NFκB and Nrf-2/HO-1 signaling crosstalkSameh Saber, Rania M Khalil, Walied S Abdo, et al.
International Immunopharmacology|May 13, 2025
Verapamil inhibits TXNIP-dependent NLRP3 Inflammasome activation in an ulcerative colitis rat model: A new evolving role of the calcium channel blockerAhmed Shawky, Sameh Saber, Eman M Abd El-Kader, et al.
AMB Express|March 5, 2025
The coadministration of Lactobacillus probiotic augments the antitumor effect of telmisartan in ratsAhmed M El-Baz, Amany A El-Mahmoudy, Sameh Saber, et al.
International Immunopharmacology|November 8, 2024
Diltiazem mitigates acute liver injury by targeting NFκB-TXNIP/NLRP3 axis in Rats: New insights beyond calcium channel blockadeFatma Elnaghy, George S G Shehatou, Eman M Abd El-Kader, et al.
Molecular Pharmaceutics|August 16, 2023
Lactosylated Chitosan Nanoparticles Potentiate the Anticancer Effects of Telmisartan In Vitro and in a <i>N</i>-Nitrosodiethylamine-Induced Mice Model of Hepatocellular CarcinomaMohamed Nasr, Ahmed Y Kira, Sameh Saber, et al.
AAPS Pharmscitech|June 23, 2023
Telmisartan-Loaded Lactosylated Chitosan Nanoparticles as a Liver Specific Delivery System: Synthesis, Optimization and Targeting EfficiencyMohamed Nasr, Ahmed Y Kira, Sameh Saber, et al.
Cancer Chemotherapy and Pharmacology|January 29, 2020
Novel complementary antitumour effects of celastrol and metformin by targeting IκBκB, apoptosis and NLRP3 inflammasome activation in diethylnitrosamine-induced murine hepatocarcinogenesisSameh Saber, Amal M H Ghanim, Eman El-Ahwany, et al.
Pageof 15